Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria

West African Journal of Medicine

Volumn 26, Issue 2, 2007, Pages 143-147

  Anorlu, Rose I ^a   Igwilo, C I ^a   Akanmu, A S ^a   Banjo, A A F ^b   Odunukwe, N N ^c   Okany, C C ^a   Abudu, O O ^a   Dim, S T ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

^c NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

Cervical smears; HIV; Nigeria; Squamous intraepithelial lesion

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; NIGERIA; PREVALENCE; SCHOOL CHILD; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; EPIDEMIOLOGIC STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 34848842437     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Federal Ministry of Health/National Action Committee on AIDS. HIV/AIDS in Nigeria: Overview of Epidemic. Abuja: Federal Ministry of Health; 2002
2. Federal Ministry of Health/National AIDS/STD Control Programme. 2003 National HIV Sero-prevalence Sentinel Survey. Abuja: Federal Ministry of Health; 2004
3. Nnatu SN, Durosinmi-Etti FA. The problems with the management of carcinoma of the cervix in Nigeria - The Lagos Experience. East Afr. Med. J. 1985 62: 347-54
4. Anorlu RI, Orakwue CO, Oyeneyin L, Abudu OO. Late presentation of patients with cervical cancer to a tertiary hospital: what is responsible? Eur J Gynae Oncology 2004; 25: 729-32.
5. Thomas J O, Ojemakinde O, Izebranye I. Current concepts in cervical carcinogenesis and new perspectives. Archives of Ibadan Medicine 2002; 1: 36-9.
6. Wright TC, Ellerbrock, TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears. Obstet Gynecol 1994; 84: 591-4.
7. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol. 1998; 68: 233-9.
8. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031-1037
9. Centre for Disease Control (CDC). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17): 1-19.
10. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Toure P et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003; 188: 555-63.
11. Massad LS, Riester KS, Anastos KM, Fruchter RG, Palefsky JM, Burk RD et al Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr 1999; 21: 33-41.
12. Federal Ministry of Health/National Action Committee on AIDS. HIV/AIDS in Nigeria-overview of epidemic. Abuja: Federal Ministry of Health; 2002.
13. National Population Commission. National Population Census. Abuja: National Population Commission; 1991
14. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnosis. JAMA 1989; 262: 931-4
15. Anorlu RI, Abdul-Kareem F, Abudu OO, Oyekan O. Cervical cytology in an urban population in Lagos. J Obstet Gynaecol 2003; 3: 285-8
16. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW et al. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 1992; 45-48
17. Leroy V, Ladner J, De Clercq A, Meheus A, Nyiraziraje M, Karita E et al. Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross-sectional study. Kigali, Rwanda. Sex Transm Inf 1999; 75: 103-106.
18. Joshi S, Chandorkar A, Krishnan G, Walimbe A, Gangakhedkar R, Risbud A, et al. Cervical intraepithelial changes & HIV infection in women attending sexually transmitted disease clinics in Pune, India. Indian J Med Res. 2001; 113: 161-169.
19. Womack SD, Chirenje ZM, Gaffilin L, Blumennthal PD, McGrath JA, Chipato T et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J. Cancer 2000; 85: 206-210.
20. La Ruche G, Leroy V, Mensah-Ado I, Bergeron C, Diomande M, Sylla-Koko F et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998; 76: 480-486.
21. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, the role of concurrent HIV-1 infection. Int J Gynecol Obstet 1999; 65: 171-178.
22. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynaecol Oncol 2000; 77: 460-463.
23. Moodley M, Mould S. Invasive cervical cancer and human immunodeficiency virus (HIV) infection in KwaZulu-Natal, South Africa. J Obstet Gynaecol. 2005; 25: 706-710.
24. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasseibald V, Hickey ID et al. Accuracy of the Papniciaou test in screening for the follow-up of cervical cytology abnormalities: a systematic review. Ann Inter Med 2000; 132: 810-819.